Histone deacetylase inhibitors as a new anticancer option: How far can we go with expectations? delivery systems.
Garmpi A, Garmpis N, Damaskos C, Valsami S, Spartalis E, Lavaris A, Patelis N, Margonis GA, Apostolou KG, Spartalis M, Andreatos N, Diamantis E, Tsivelekas K, Moschos MM, Nonni A, Tsourouflis G, Markatos K, Antoniou EA, Kontzoglou K, Nikiteas N, Dimitroulis D.
Garmpi A, et al. Among authors: tsourouflis g.
J BUON. 2018 Jul-Aug;23(4):846-861.
J BUON. 2018.
PMID: 30358185
Free article.